FindTrial
Sign In

Post operative analgesia of Nefopam in laparoscopic surgery

COMPARISION OF POST OPERATIVE ANALGESIC EFFECT OF NEFOPAM HYDROCHLORIDE AND DICLOFENAC SODIUM IN LAPROSCOPIC SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037110
Enrollment
30
Registered
2021-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K37- Unspecified appendicitis

Interventions

Intervention1: NEFOPAM HYDROCHLORIDE: 0.3-0.4mg/kg IV given before 15-20 mins of Extubation Control Intervention1: Diclofenac Sodium: 1.5mg/kg IV given before 15-20 mins of Extubation

Sponsors

Department of Anaesthesiology P D U medical college Rajkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Abdominal Laparoscopic surgeries of ASA grade 1 ,2, 3

Exclusion criteria

Exclusion criteria: patient refusal, hepatic and renal insufficiency, patients on tricyclic anti depressants and MOA inhibitor , pregnancy and lactation , convulsive disorder

Design outcomes

Primary

MeasureTime frame
Nefopam as compared to NSAIDS , due to its opioid sparing effect and no effect on platelet function it may prove to be useful non opioid adjuvant in laparoscopic abdominal surgeriesTimepoint: 6-10 hours—

Secondary

MeasureTime frame
decreased post operative nausea and vomiting and post operative shiveringTimepoint: Baseline,1 hour , 2 hour—

Countries

India

Contacts

Public ContactDarshan n

P D U Medical college , Rajkot

drvandanapithadia@yahoo.com07353543443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026